National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
Clinical Trials and Translational Research Advisory Committee

Presentations from the Meeting Held November 7, 2018
(Presentation File Format - PDF --> Get Adobe Reader)

November 7
NIH VIDEOCAST  

CALL TO ORDER AND OPENING REMARKS  
Call to Order and Opening Remarks Dr. Loehrer

NCI DIRECTOR'S UPDATE  
NCI Director's Update Dr. Sharpless

PROGRESS IN PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) RESEARCH WORKING GROUP REPORT  
Progress in Pancreatic Ductal Adenocarcinoma (PDAC) Research Working Group Report Dr. Abbruzzese

CANCER PREVENTION: SUCCESSES, OPPORTUNITIES AND CHALLENGES  
Vision for Cancer Prevention and Implementation
Long-Term Prostate Cancer Risk in the Prostate Cancer Prevention Trial (PCPT)
Cancer Preventive Agent Development Program: The Early Phase Pipeline
The NCI Cancer Prevention Steering Committee: Opportunities and Challenges
Dr. Kramer
Drs. Thompson & Unger
Dr. Szabo
Dr. Hawk

ANALYSIS OF NCORP ACCRUAL PERFORMANCE  
Analysis of NCORP Accrual Performance Dr. McCaskill-Stevens

FINDING CANCER TRIALS COLLABORATIVE  
Finding Cancer Trials Collaborative Dr. Sarosy

LEGISLATIVE UPDATE  
Legislative Update
Legislative Report
Ms. Gibbons

ONGOING AND NEW BUSINESS  
Ongoing and New Business
Recognitions
Quantitative Imaging Network Working Group
Summary of the July CTAC Discussion
Dr. Loehrer
Drs. Loehrer & Doroshow
Dr. Eary

CONCLUDING REMARKS  
Concluding Remarks
July 2018 Action Items Sheet
Dr. Loehrer


Top